Iovance Biotherapeutics Inc.
IOVA | NASDAQ
$10.38
+$0.19 (+1.86%)
Sep 22, 2026, 11:03 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -47.32M | -79.05M | -71.9M | -91.25M | -111.66M | -116.16M | -78.56M | -83.54M | -97.1M | -112.98M | -116.38M | -113.76M | -106.53M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M | -86.12M | -81.35M | -75.45M |
Depreciation & Amortization | 6.62M | 7.59M | 17.86M | 11.68M | 11.94M | 11.07M | 11.69M | 11.15M | 10.86M | 9.91M | 9.71M | 9.88M | 7.84M | 5.7M | 5.71M | 5.2M | 5.2M | 4.98M | 4.58M | 3.97M | 2.78M | 2.77M |
Stock-Based Compensation | 11.73M | 11.27M | 11.82M | 11.9M | 14.94M | 22.92M | 30.98M | 31.01M | 30.47M | 17.18M | 14.4M | 15.82M | 16.74M | 15.67M | 19.51M | 19.78M | 22.47M | 22.27M | 19.1M | 19.31M | 14.41M | 16.94M |
Other Working Capital | 24.53M | -24.53M | 17.61M | 5.87M | -9.65M | -4.11M | -4.89M | 7.28M | 11.91M | -19.92M | 1.39M | 15.27M | -2.03M | -15.85M | 1.45M | 6.59M | -8.63M | -8.19M | 13.24M | 9.53M | 3.39M | -8.71M |
Other Non-Cash Items | -43.39M | 1.66M | -3.23M | -88K | 6.15M | -2.04M | -981K | -2.75M | -2.49M | -2.43M | -1.83M | -666K | -58K | -978K | -571K | 133K | 22.97M | 855K | 19.94M | 1.32M | 1.8M | 2.07M |
Deferred Income Tax | -1.37M | -665K | 184K | -2.41M | 1.99M | -1.84M | 1.56M | -1.52M | -1.46M | -1.41M | -1.76M | -1.24M | -477K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 12.88M | -12.88M | -7.29M | -8.53M | 9.19M | -17.63M | -37.98M | -13.32M | -38.71M | -32.55M | 11.89M | 5.89M | -11.47M | -12.83M | 3M | 10.85M | -6.46M | -10.29M | 20.96M | 3.84M | 8.36M | -8.72M |
Operating Cash Flow | -60.84M | -72.07M | -52.57M | -78.7M | -67.45M | -103.69M | -73.3M | -58.97M | -98.43M | -122.28M | -83.97M | -84.08M | -93.95M | -99.82M | -77.67M | -63.65M | -77.64M | -73.8M | -53.85M | -57.69M | -54.01M | -62.39M |
Capital Expenditures | -5.44M | -6.61M | -9.32M | -10.84M | -7.46M | -6.21M | -4.17M | -2.29M | -442K | -4.17M | -3.53M | -3.58M | -9.52M | -5.66M | -3.02M | -1.39M | -4.58M | -11.44M | -7.57M | -9.69M | -9.62M | -10.71M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -52.57M | 253K | -3.38M | -209.51M | n/a | -3.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -129.61M | -56M | -59.91M | -92.14M | -68.7M | -97.92M | -88.16M | -156.51M | -74.34M | -141.76M | -107.57M | -93.01M | n/a | -5.32M | -95.63M | -64.35M | -40.29M | -45.55M | -141.55M | -201.87M | -311.41M | -70.37M |
Sales Maturities Of Investments | 61M | 74M | 70M | 120M | 90M | 120M | 116M | 110M | 115M | 87M | 38M | 20.95M | 62.25M | 164.38M | 99.11M | 139.45M | 140.63M | 143.51M | 218.46M | 224.3M | 161.87M | 158.29M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -74.05M | 11.39M | 775K | 17.01M | 13.84M | 15.87M | 23.68M | -48.8M | 40.22M | -111.51M | -72.85M | -79.01M | -156.78M | 153.4M | 461K | 73.72M | 95.76M | 86.52M | 69.34M | 12.75M | -159.17M | 77.21M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M |
Common Stock Repurchased | 861K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 49.29M | -4.18M | -445K | -466K | 165K | -5.63M | -880K | -5.56M | 952K | -4.34M | 961K | -379K | 1.03M | -1.93M | 1.07M | 225K | -2.65M | 1.42M | 4.15M | 20.77M | 3.71M | 6.48M |
Financial Cash Flow | 49.29M | 94.34M | 56.17M | 88.06M | 13.23M | 143.32M | 2.31M | 41.95M | 152.83M | 193.58M | 962K | 202.8M | 1.03M | 258.17M | 190.58M | 225K | -2.07M | 1.42M | 4.15M | 20.77M | 163.98M | 50.36M |
Net Cash Flow | 110.78M | -157.09M | 4.96M | 25.69M | -39.64M | 56M | -48.49M | -64.57M | 94.49M | -40.7M | -152.83M | 37.71M | -253.47M | 311.75M | 113.37M | 10.29M | 15.72M | 14.13M | 19.64M | -24.17M | -49.19M | 65.18M |
Free Cash Flow | -66.28M | -78.68M | -61.89M | -89.55M | -74.91M | -109.91M | -77.46M | -61.26M | -98.87M | -126.45M | -87.5M | -87.66M | -103.47M | -105.48M | -80.69M | -65.04M | -82.21M | -85.24M | -61.42M | -67.38M | -63.62M | -73.1M |
Adj. Free Cash Flow | -78.02M | -89.95M | -73.7M | -101.45M | -89.85M | -132.82M | -108.44M | -92.27M | -129.34M | -143.63M | -101.9M | -103.48M | -120.21M | -121.14M | -100.2M | -84.82M | -104.68M | -107.51M | -80.52M | -86.68M | -78.04M | -90.04M |
Maintenance CapEx | -5.44M | -6.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -602.36K | n/a | n/a | n/a | -5.66M | -3.02M | -1.39M | -4.58M | -4.98M | -4.58M | -3.97M | -2.78M | -2.77M |
Growth CapEx | n/a | n/a | -9.32M | -10.84M | -7.46M | -6.21M | -4.17M | -2.29M | -442K | -3.57M | -3.53M | -3.58M | -9.52M | n/a | n/a | n/a | n/a | -6.46M | -2.98M | -5.72M | -6.84M | -7.93M |
Owner Earnings | -66.28M | -78.68M | -52.57M | -78.7M | -67.45M | -103.69M | -73.3M | -58.97M | -98.43M | -122.88M | -83.97M | -84.08M | -93.95M | -105.48M | -80.69M | -65.04M | -82.21M | -78.78M | -58.43M | -61.66M | -56.79M | -65.17M |
Add to Watchlist
Select watchlists to add or remove IOVA